1. Home
  2. DCTH vs CURI Comparison

DCTH vs CURI Comparison

Compare DCTH & CURI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DCTH
  • CURI
  • Stock Information
  • Founded
  • DCTH 1988
  • CURI N/A
  • Country
  • DCTH United States
  • CURI United States
  • Employees
  • DCTH 76
  • CURI N/A
  • Industry
  • DCTH Medical/Dental Instruments
  • CURI Movies/Entertainment
  • Sector
  • DCTH Health Care
  • CURI Consumer Discretionary
  • Exchange
  • DCTH Nasdaq
  • CURI Nasdaq
  • Market Cap
  • DCTH 426.3M
  • CURI 394.5M
  • IPO Year
  • DCTH N/A
  • CURI N/A
  • Fundamental
  • Price
  • DCTH $11.52
  • CURI $4.49
  • Analyst Decision
  • DCTH Strong Buy
  • CURI Strong Buy
  • Analyst Count
  • DCTH 4
  • CURI 2
  • Target Price
  • DCTH $24.00
  • CURI $5.40
  • AVG Volume (30 Days)
  • DCTH 850.4K
  • CURI 833.1K
  • Earning Date
  • DCTH 08-04-2025
  • CURI 08-12-2025
  • Dividend Yield
  • DCTH N/A
  • CURI 7.14%
  • EPS Growth
  • DCTH N/A
  • CURI N/A
  • EPS
  • DCTH N/A
  • CURI N/A
  • Revenue
  • DCTH $53,850,000.00
  • CURI $54,223,000.00
  • Revenue This Year
  • DCTH $155.42
  • CURI $24.74
  • Revenue Next Year
  • DCTH $37.93
  • CURI $13.30
  • P/E Ratio
  • DCTH N/A
  • CURI N/A
  • Revenue Growth
  • DCTH 1068.87
  • CURI N/A
  • 52 Week Low
  • DCTH $7.17
  • CURI $0.99
  • 52 Week High
  • DCTH $18.23
  • CURI $7.15
  • Technical
  • Relative Strength Index (RSI)
  • DCTH 32.83
  • CURI 38.56
  • Support Level
  • DCTH $12.11
  • CURI $4.55
  • Resistance Level
  • DCTH $14.15
  • CURI $4.68
  • Average True Range (ATR)
  • DCTH 0.57
  • CURI 0.32
  • MACD
  • DCTH -0.16
  • CURI -0.09
  • Stochastic Oscillator
  • DCTH 9.67
  • CURI 3.72

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

About CURI CuriosityStream Inc.

CuriosityStream Inc is a media and entertainment company. It offers premium video programming across the principal categories of factual entertainment, including science, history, society, nature, lifestyle, and technology. Its mission is to provide premium real entertainment that informs, enchants, and inspires. Its product and services are Direct to Consumer Business, Partner Direct Business, Bundled Distribution, Content Licensing, Enterprise Subscriptions and Others. The majority of the revenue comes from the Direct to direct-to-consumer business.

Share on Social Networks: